key: cord-0977468-le034mvq
authors: Saura, Marta; Zaragoza, Carlos; McMillan, Audrey; Quick, Richard A; Hohenadl, Christine; Lowenstein, John M; Lowenstein, Charles J
title: An Antiviral Mechanism of Nitric Oxide: Inhibition of a Viral Protease
date: 1999-01-01
journal: Immunity
DOI: 10.1016/s1074-7613(00)80003-5
sha: e2cd9385b6fe84f42f1f6d0c99053c3ec6e2bcdb
doc_id: 977468
cord_uid: le034mvq

Although nitric oxide (NO) kills or inhibits the replication of a variety of intracellular pathogens, the antimicrobial mechanisms of NO are unknown. Here, we identify a viral protease as a target of NO. The life cycle of many viruses depends upon viral proteases that cleave viral polyproteins into individual polypeptides. NO inactivates the Coxsackievirus protease 3C, an enzyme necessary for the replication of Coxsackievirus. NO S-nitrosylates the cysteine residue in the active site of protease 3C, inhibiting protease activity and interrupting the viral life cycle. Substituting a serine residue for the active site cysteine renders protease 3C resistant to NO inhibition. Since cysteine proteases are critical for virulence or replication of many viruses, bacteria, and parasites, S-nitrosylation of pathogen cysteine proteases may be a general mechanism of antimicrobial host defenses.

macrophages, activated or not with lipopolysaccharide and interferon-␥. The macrophages were separated from the infected HeLa cells by a 0.4 M pore size membrane, which would allow the passage of NO from macrophages to infected cells. The NOS inhibitor nitroarginine-methyl-ester (NAME) was added to some cocultures of infected HeLa cells and activated macrophages, in order to confirm that any antiviral effect of activated macrophages was a result of NO, and not inhibitor NAME (0-10 mM). Cells were harvested 5 hr after infection (LPS or IFN alone have no effect upon viral replication and cell lysates analyzed for CVB3 polypeptide 2C as above.

in HeLa cells [ Figure 2C ].) Thus, NO synthesized by activated macrophages can diffuse into infected cells and boundary between the structural proteins and the noninhibit the viral proteases that process the viral polystructural proteins, VP1 and 2A, producing two polyproproteins.

teins. The protease 3C pro is thought to cleave the re-Since exogenous and endogenous NO inhibit proteosulting polyproteins into ten viral polypeptides, including lytic processing of Coxsackievirus polyproteins, we the cleavage of 2BC into 2B To test the activity of recombinant protease, purified 3C pro was incubated with the protease substrate GST-3B-3C T and the reaction mixture analyzed by immunoblotting with an antibody to GST. Purified 3C pro is capable of cleaving the polyprotein GST-3B-3C T , as detected by immunoblotting ( Figure 3B , immunoblot lanes 1 and 2).

In order to measure the susceptibility of 3C pro to NO, we added a variety of NO donors or their controls to 3C pro and a protease substrate. The NO donor SNAP inhibits the proteolytic activity of 3C pro in a dose-dependent manner, while its control acetyl-penicillamine (AP), which has no nitroso group, has no effect ( Figure 3B ). DTT, an agent capable of reducing the nitrosylation of cysteine residues, reverses the NO inhibition of 3C pro . Another NO donor, spermine NONOate, also inhibits 3C pro cleavage of GST-3B-3CT. DTT also reverses this effect ( Figure 3C ).

To confirm these results, we used luciferase as another protease substrate (Holzman and Baldwin, 1980; Gorbalenya and Svitkin, 1983; Thompson et al., 1997) . Firefly luciferase serves as a 3C pro substrate because it contains the 3C pro motif AXXQG. Cleavage of luciferase was measured by monitoring luciferase activity. 3C pro cleaves luciferase in a dose-and time-dependent manner ( Figures 4A and 4B ). The NO donors SNAP or spermine NONOate but not their corresponding control drugs inhibit 3C pro activity, and these inhibitions are reversed by DTT ( Figure 4C) . It was previously shown that the (C) The cleavage experiment was then repeated using spermine Zhang et al., 1996) . Purified 3C pro was incubated with NONOate (SP-NO) as an NO donor or its control compound spermine (SP). n ϭ 3 Ϯ SD, and * p Ͻ 0.05. NO donors for 1 hr and then dialyzed. 5,5Ј-Dithiobis (2-nitrobenzoic acid) was added, the increase of absorbance at 412 nm was measured, and the concentra- (Stamler et al., 1992a (Stamler et al., , 1992b Stamler, 1994) , we hypothtion of thiols was calculated from the molar extinction esized that NO inhibits the CVB3 3C pro . coefficient of the nitrothiobenzoate ion. NO donors but We therefore prepared pure 3C pro and various protenot their corresponding control compounds eliminate ase substrates. We subcloned the cDNA encoding 3C pro the sulfhydryl group from purified 3C pro over time (Figinto a bacterial Nitrosylation of the 3C pro active site Cys 147 . 3C pro was exposed to NO at various times was assayed using a luminometer. n ϭ 3 Ϯ SD. donors or their controls, then incubated with HgCl 2 , and the amount (B) Increasing amounts of 3C pro were added to luciferase for 3 hr, of nitrite released was measured by the Griess reaction. n ϭ 4 Ϯ SD. and the amount of luciferase assayed as above. n ϭ 3 Ϯ SD. (C) Luciferase was incubated alone, or in the presence of 3C pro with the following additions: the control compound AP, the NO donor SNAP, SNAP and DTT, the control compound spermine (SP), the NO has no effect upon mutant C147S 3C pro activity, nor does NO donor spermine NONOate (SP-NO), or spermine NONOate and DTT change mutant protease activity. Thus, the Cys 147 DTT. n ϭ 3 Ϯ SD. of the catalytic triad is critical in determining the susceptibility of 3C pro to NO. cysteine residue. Since the active site Cys 147 is the only cysteine residue in 3C pro , the data imply that NO nitrosy-Discussion lates the active site cysteine residue.

The major finding of this study is that NO inhibits Coxsackievirus replication at least in part by nitrosylating Mutating the CVB3 Protease Active Site Cysteine to Serine Renders the Protease the cysteine residue in the active site of a viral protease, thereby drastically reducing the activity of this enzyme.

This protease is critical to the life cycle of Picornaviruses. Nitrosylation of cysteine residues is one mecha-responsible for the inhibition of 3C pro , we created a mutant protease by PCR-directed mutagenesis, substitut-nism by which NO can directly modify a polypeptide, and NO in theory can reduce the activity of an enzyme ing a serine for the cysteine at position 147. The resultant mutant protease, C147S 3C pro , still has catalytic activity, if its catalytic site includes a cysteine residue (Stamler et al., 1992b (Stamler et al., , 1997 Stamler, 1994) . For example, NO although at a level greatly reduced from wild-type protease, as Komatsu, 1998) . NO production may thus be a general 3C pro processing acts upstream of viral RNA synthesis mechanism by which the host defends itself against and is necessary to generate 3D pol . Therefore, nitrosylainfection by viruses and other pathogens whose life cytion and inactivation of 3C pro would be expected to block cle depends upon cysteine proteases. not only viral protein processing but also viral RNA synthesis.

Although our data suggest that NO inhibits activity of

Coxsackievirus protease 3C pro , there are other potential viral targets of NO as well. For example, NO could affect tion of other viruses that encode cysteine proteases,

Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors

Redox signaling: nitrosylation and related target interactions of nitric oxide

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds

Biochemistry of nitric oxide and its redox-activated forms

NO Signals: translocation, regulation, and a consensus motif

Mutation of a protease-sensitive region in firefly luciferase alters light emission properties

Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis

Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin

Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo

Nitric oxide inhibition of coxsackievirus replication in vitro

The role of NOS2 in coxsackievirus myocarditis

Nitrosation of tryptophan residue(s) in serumalbumion and model dipeptides